Home › Funds › Compagnie Lombard Odier SCmA › ABT
Compagnie Lombard Odier SCmA position in ABT
ABBOTT LABORATORIES · Health Care
Compagnie Lombard Odier SCmA reported holding 542,153 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$53.6M, representing 0.66% of its reported portfolio and ranking #31 among its reported holdings. Compagnie Lombard Odier SCmA has disclosed ABT holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Compagnie Lombard Odier SCmA's ABT position evolved
Compagnie Lombard Odier SCmA first disclosed a stake in ABT in Q3 2023 at 782,305 shares (US$75.8M). The position peaked in Q1 2025 at 754,559 shares, worth US$100.1M. Across 6 filings, Compagnie Lombard Odier SCmA increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 542,153 shares valued at US$53.6M — an increase of 109,335 shares quarter over quarter.. Notable position changes include a 25% increase in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 782.30K | $75.77M | New |
| Q4 2023 | 833.30K | $91.72M | Add |
| Q1 2025 | 754.56K | $100.09M | New |
| Q4 2025 | 675.06K | $84.58M | New |
| Q2 2026 | 432.82K | $39.27M | New |
| Q3 2026 | 542.15K | $53.58M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 44.98M sh · $4.45B · Q3 2026
- Capital International Investors 35.46M sh · $3.51B · Q3 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Franklin Resources 20.44M sh · $2.36B · Q3 2026
- Deutsche Bank AG 17.69M sh · $1.75B · Q3 2026
- MFS Investment Management 14.93M sh · $1.48B · Q3 2026
More on Compagnie Lombard Odier SCmA
FAQ
How long has Compagnie Lombard Odier SCmA held ABT?
Compagnie Lombard Odier SCmA has disclosed ABT holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is Compagnie Lombard Odier SCmA's current position in ABT?
As of Q3 2026, Compagnie Lombard Odier SCmA holds 542.15K shares of ABT (ABBOTT LABORATORIES), valued at $53.58M, representing 0.66% of its reported portfolio and ranking #31.
Has Compagnie Lombard Odier SCmA been buying or selling ABT?
In the latest 13F filing (Q3 2026), Compagnie Lombard Odier SCmA increased its position in ABT. The position peaked in Q1 2025 at 754.56K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.